mRNA

(redirected from messenger RNA)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to messenger RNA: DNA, ribosomal RNA

mRNA

McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
This particular riboswitch resides in the messenger RNA that carries instructions for the enzyme responsible for the production of glucosamine-6-phosphate, called GlmS.
The editor (whose professional affiliation is not given) introduces messenger RNA (mRNA) as the mediator between DNA and proteins, transferring information to a particular gene from a strand of DNA via the process of transcription.
These siRNAs bind with other molecules to form the RNA-induced silencing complex, which allows the siRNAs to target specific messenger RNAs to block production of protein.
United States-based Merck has signed a license and three-year research collaboration with Moderna Therapeutics, a biotechnology company that is researching and developing protein therapies based on novel messenger RNA technology, it was reported on Thursday.
Gene expression involves transcribing a gene's deoxyribonucleic acid (DNA) message into molecules of messenger RNA, which migrate from the nucleus of a cell into the surrounding cytoplasm to serve as blueprints for protein construction.
It copies gene sequences from DNA to create a single-stranded nucleic acid called messenger RNA. Other parts of the cell then use the messenger RNA to direct protein assembly.
He contributes to emerging knowledge, relevant to pharmaceutical intervention, of the enzymes involved in generating PTMs, i.e., changes that occur after messenger RNA code has been translated into the amino acid sequence code of nascent proteins.
- Indianapolis, Indiana-based global pharmaceuticals specialist Eli Lilly and Company (NYSE: LLY) and Tubingen, Germany-based messenger RNA technology specialist CureVac AG have formed a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive technology, the company said.
The allowed subject matter is directed to, among other things, methods of treating cancer with small interfering RNA (siRNA) or antisense molecules that target the PKN-3 messenger RNA (mRNA).